Back to VRTX Stock Lookup

Vertex Pharma (VRTX) – Company Press Releases

Mar 23, 2015 07:45 AM Vertex Announces Data from 12-Week Phase 2 Safety Study of VX-661 in Combination with Ivacaftor in People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
Mar 18, 2015 07:46 AM Vertex Receives U.S. Food and Drug Administration Approval of KALYDECO® (ivacaftor) for Children with Cystic Fibrosis Ages 2 to 5 who have Specific Mutations in the CFTR Gene
Feb 11, 2015 04:05 PM Vertex to Present at Upcoming Investor Conferences
Jan 28, 2015 04:01 PM Vertex Reports Full-Year and Fourth Quarter 2014 Financial Results and Provides Guidance for 2015
Jan 11, 2015 08:49 PM Vertex Outlines 2015 Business Priorities to Support the Development, Approval and Launch of New Medicines for the Treatment of People with Cystic Fibrosis
Jan 6, 2015 04:01 PM Vertex Announces Upcoming Presentation at the J.P. Morgan Healthcare Conference and Date of Fourth Quarter and Full Year 2014 Financial Results

Back to VRTX Stock Lookup